Close Menu

NEW YORK ─ The International Atomic Energy Agency (IAEA) said Wednesday that Takeda Pharmaceutical will donate 500 million yen ($4.7 million) to support the agency's initiative to help countries combat the COVID-19 pandemic, which involves the supply of RT-PCR tests to laboratories around the world.

The financial contribution from the Tokyo-based biopharmaceutical firm will enable the IAEA to increase its emergency assistance to agency member states that are in need of quick and reliable diagnostic methods to contain the coronavirus, IAEA said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.